Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis.

Nat Commun · 2023 · PMC10570306 · PMID 37828014

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp < 1.06 −6actually significant

Image-based HSPC fractions showed highly significant concordance with the clinically determined peripheral blood (PB) blast percentages ( p < 1.06 −6 ; Supplementary Fig. 2d, e ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.